kccu

Jim Zarroli

Jim Zarroli is an NPR correspondent based in New York. He covers economics and business news.

Over the years, he has reported on recessions and booms, crashes and rallies, and a long string of tax dodgers, insider traders, and Ponzi schemers. Most recently, he has focused on trade and the job market. He also worked as part of a team covering President Trump's business interests.

Before moving into his current role, Zarroli served as a New York-based general assignment reporter for NPR News. While in this position, he reported from the United Nations and was also involved in NPR's coverage of Hurricane Katrina, the London transit bombings, and the Fukushima earthquake.

Before joining NPR in 1996, Zarroli worked for the Pittsburgh Press and wrote for various print publications.

He lives in Manhattan, loves to read, and is a devoted (but not at all fast) runner.

Zarroli grew up in Wilmington, Delaware, in a family of six kids and graduated from Pennsylvania State University.

Updated at 4:25 pm

Hopes for a vaccine have brought good times back to financial markets.

Stocks extended a recent rally Monday, with the Dow Jones Industrial Average and the S&P 500 closing at record highs, after Moderna became the second drugmaker to tout progress toward developing an effective COVID-19 vaccine.

The Dow ended the day up 471 points, or 1.6%, and is now close to reaching 30,000 points for the first time. It appears to have put behind it for now a period of uncertainty ahead of the election that hurt markets.

ARI SHAPIRO, HOST:

Euphoria broke out on Wall Street today following the news of that successful vaccine trial. The Dow and the S&P 500 soared to record highs early in the day before giving up some of their gains. But here's a twist. Stocks for companies that have benefited from stay-at-home orders, like Zoom, Netflix and Amazon - their share prices cratered. NPR's Jim Zarroli reports.

JIM ZARROLI, BYLINE: Stocks went gangbusters as soon as the market opened. There was no secret why.

Updated at 4:35 p.m. ET

Euphoria broke out Monday on Wall Street after promising news of a vaccine trial provided a major dose of hope for the global economy.

The powerful rally was sparked after Pfizer and its partner BioNTech said the experimental COVID-19 vaccine was more than 90% effective.

The stock market racked up its best week since April despite the turmoil of an election that's still unresolved.

While the major stock indexes mostly finished a bit lower Friday, the drop wasn't enough to offset four days of strong gains. The S&P 500 surged 7.3% for the week, while the Dow Jones Industrial Average rose about 1,800 points, an increase of 6.9%.

Updated at 4:23 p.m. ET

Wall Street seemed to love the prospect of a "blue wave" just a few days ago. Now that Democrats appear less likely to get the landslide they hoped for, investors are happy about that as well.

Stock prices began climbing early in the week, when polls showed that Democrats could capture both the Senate and the White House, giving them complete control of Washington.

The Dow Jones Industrial Average finished 1.6% higher on Monday and then rose more than 2% before polls closed on Election Day.

Pages